Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
2.
Med J Aust ; 1 Suppl 1: 6-8, 1978 Mar 25.
Article in English | MEDLINE | ID: mdl-307107

ABSTRACT

One hundred and sixty-three Australian Aboriginals, who were aged from four months to 60 years, were examined clinically and otologically. Audiometric tests were completed on 110 of these subjects. On the assumptions that the aural health of these people has remained stable for many years, the cross-sectional data which were obtained have been used to infer the natural history of ear disease. Seromucinous otitis media is manifest as a disease of early childhood, which recovers spontaneously in most cases and has no obvious sequelae. Perforated tympanic membranes likewise seem to heal spontaneously in the majority of cases. The evidence suggests that hearing loss is the main problem and treatment should be directed towards the level of hearing loss and its effects.


Subject(s)
Ear, Middle , Native Hawaiian or Other Pacific Islander , Adolescent , Adult , Audiometry , Australia , Child , Child, Preschool , Chronic Disease , Cross-Sectional Studies , Ear Diseases/diagnosis , Ear Diseases/epidemiology , Endoscopy , Humans , Infant , Middle Aged
3.
Am J Hum Genet ; 28(2): 179-88, 1976 Mar.
Article in English | MEDLINE | ID: mdl-817597

ABSTRACT

The jungle habitat of the Temuan aborigines harbors a variety of infectious diseases, the most notable being malaria. Our study of 15 genetic systems in the Temuan revealed substantial polymorphism and within-population genetic diversity. The polymorphisms for Hb beta, G6PD, and El are of interest in regard to genetic adaptation to malaria. Among the polymorphisms investigated we conclude that G6PD deficiency and elliptocytosis are likely to have malaria-resistant effects as evidenced by their low association with malarial parasitemia or their higher frequency in adults than in children. These findings suggest that the malarial habitat of the Temuans is livable in the long range sense for them because of the cluster of malaria-resistant alleles in their gene pool (G6PD)-, El, and possibly, but not tested here because of its low frequency, Hb beta E). The same condition probably holds for the Semai, the nearest aborigine neighbors of the Temuan (although the Semai have not been tested for malarial parasitemia and for these polymorphisms simultaneously), since the Semai have substantial Hb betaE, G6PD-, and El. The Temuan have a cultural identity system of rituals, beliefs, and certain aspects of language which effectively isolates them genetically from Malays and other nonaborigines. This system hinders the dilution of the malaria-resistant alleles of the Temuan gene pool with the malaria-susceptible alleles of the nonaborigine gene pools.


Subject(s)
Gene Frequency , Malaria/epidemiology , Polymorphism, Genetic , Carbonic Anhydrases/blood , Female , Glucose-6-Phosphate Isomerase/blood , Glucosephosphate Dehydrogenase/blood , Haptoglobins/metabolism , Hemoglobins/metabolism , Humans , Isoenzymes , L-Lactate Dehydrogenase/blood , Malaysia , Male , Phosphoglucomutase/blood , Phosphogluconate Dehydrogenase/blood , Serum Albumin
5.
Ann Trop Med Parasitol ; 69(2): 141-5, 1975 Jun.
Article in English | MEDLINE | ID: mdl-1155986

ABSTRACT

Serum was collected from six adults participating in a field trial of sulfadoxine and pyrimethamine in combination which was being administered once monthly for malaria suppression. Samples were drawn during each of two consecutive months three hours, and 7, 14 and 28 days following a dose of 1 500 mg sulfadoxine. Serum sulfadoxine concentration was measured using the method of Bratton and Marshall (1939). Initial serum concentrations averaged 19-9 plus or minus 2-4 (SD) mg/100 ml and decayed to 6-2 plus or minus 2-8 mg/100 ml at 14 days. Serum sulfadoxine concentrations were still detectable at 28 days following a dose (2-1 plus or minus 1-5 mg/100 ml). Elimination half-time averaged 195 plus or minus 44 hours. The presistent serum concentrations of sulfadoxine following monthly doses documented here during field-use of this drug are in agreement with the successful clinical results reported for such a regimen (Lewis and Ponnampalam, 1974; O'Holohan and Hugoe-Mathews, 1971; Wolfensberger, 1971).


Subject(s)
Folic Acid Antagonists/therapeutic use , Malaria/drug therapy , Pyrimethamine/pharmacology , Sulfadoxine/pharmacology , Sulfanilamides/pharmacology , Adolescent , Adult , Dosage Forms , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Evaluation , Drug Therapy, Combination , Half-Life , Humans , India , Malaria/blood , Malaysia/ethnology , Male , Pyrimethamine/blood , Pyrimethamine/therapeutic use , Sulfadoxine/blood , Sulfadoxine/therapeutic use
6.
Med J Aust ; 1(4 Suppl): Spec suppl 38-40, 1975 May 10.
Article in English | MEDLINE | ID: mdl-1152788

ABSTRACT

A random sample of 100 Aboriginal primary school children originally examined in February, 1970, was followed up in February, 1971, and February, 1972. Over this period, the incidence of hearing loss dropped from 41% to 23%. Most of the improvement occurred in the younger children, and, while this could be attributed to treatment in a few cases, the majority of children appeared to improve spontaneously. A complete school grade of 37 children aged six years in 1970 was retested six times over a period of three years. Again, there was a general improvement, from 60% incidence of hearing loss in 1970 to 22% in 1972. Most of this improvement was spontaneous. During the three years of observation (1970, 1971, 1972), 30 Aboriginal children from Cherbourg underwent surgery including myringotomy, myringoplasty and mastoidectomy. Operative successes and failures in these children are discussed.


Subject(s)
Ear Diseases/epidemiology , Ethnicity , Hearing Disorders/epidemiology , Adolescent , Australia , Child , Child, Preschool , Cholesteatoma/surgery , Drainage , Ear Diseases/surgery , Follow-Up Studies , Hearing Disorders/surgery , Humans , Mastoid/surgery , Myringoplasty , Native Hawaiian or Other Pacific Islander , Tympanic Membrane/surgery
7.
Med J Aust ; 1(4 Suppl): Spec suppl 45-8, 1975 May 10.
Article in English | MEDLINE | ID: mdl-1152789

ABSTRACT

In an Australian Aboriginal community, 65% of all people examined had clinical evidence of pathology in the ear drum or middle ear, but active ear disease was found mainly in children. In most people, both ears showed similar clinical changes. Clinical nutritional status and hygienic factors did not correlate with the presence of ear disease. Some families had significantly more ear disease than did others, suggesting that there is some as yet unidentified familial factor.


Subject(s)
Ear Diseases/epidemiology , Ear, Middle , Ethnicity , Adolescent , Adult , Age Factors , Australia , Body Weight , Child , Child, Preschool , Chronic Disease , Ear Diseases/etiology , Ear Diseases/genetics , Humans , Hygiene , Impetigo/complications , Infant , Infant, Newborn , Lice Infestations/complications , Native Hawaiian or Other Pacific Islander , Otitis Media/epidemiology , Skinfold Thickness
8.
Ann Trop Med Parasitol ; 69(1): 1-12, 1975 Mar.
Article in English | MEDLINE | ID: mdl-1092276

ABSTRACT

A trial of suppression of malaria by administration of combined sulphadoxine-pyrimethamine tablets every 28 days was undertaken in West Malaysia during 1972. One thousand subjects were followed over a 10-month period, including control groups on placebo and on weekly chloroquine. Subjects were examined monthly for parasitaemia, drug reactions, leucopenia, teratogenicity and haemolysis among the subjects deficient in glucose-6-phosphate dehydrogenase. Rates of new infections in the placebo group were 8.0% with Plasmodium falciparum and 6.2% with P. vivax; in the group receiving weekly chloroquine, 5.1% P. falciparum and 0.3% P. vivax; and in the group receiving monthly sulphadoxine-pyrimethamine, 0.3% P. Falciparum and 1.0% P. vivax. The effective rate of cure of new infections with P. falciparum by a single suppressive dose of combined sulphadoxine-pyrimethamine given the following month was 88.7%. No serious side effects were observed.


Subject(s)
Malaria/drug therapy , Pyrimethamine/administration & dosage , Sulfadoxine/administration & dosage , Sulfanilamides/administration & dosage , Adolescent , Adult , Blood/parasitology , Child , Child, Preschool , Chloroquine/administration & dosage , Clinical Trials as Topic , Drug Combinations , Drug Evaluation , Drug Synergism , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Leukocyte Count , Male , Placebos , Plasmodium vivax , Pregnancy , Pyrimethamine/adverse effects , Sulfadoxine/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...